Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety, Efficacy and Cost-effectiveness of Transcatheter Tricuspid Valve Repair in Patients With Severe Tricuspid Regurgitation in the Netherlands.

NCT05628779 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT05628779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05628779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety, Efficacy and Cost-effectiveness of Transcatheter Tricuspid Valve Repair in Patients With Severe Tricuspid Regurgitation in the Netherlands.
Lead sponsor
St. Antonius Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 12, 2022
Completion date
November 1, 2027
Enrollment
150 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac catheterization, heart failure, right sided, tricuspid valve regurgitation, nonrheumatic, valve regurgitation, tricuspid